Immunosuppressant Indulges EBV Reactivation and Related Lymphoproliferative Disease by Inhibiting Vδ2+ T Cells Activities After Hematopoietic Transplantation for Blood Malignancies
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000208
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
BMJ